RT Journal Article
SR Electronic
T1 Operative survival in patients with acute aortic disease in the era of newer oral anticoagulants
JF Open Heart
JO Open Heart
FD British Cardiovascular Society
SP e001278
DO 10.1136/openhrt-2020-001278
VO 7
IS 2
A1 Johannes Lagethon Bjørnstad
A1 Adil Mahboob Khan
A1 Henriette Røed-Undlien
A1 Bjørn Bendz
A1 Ståle Nygård
A1 Tom Nilsen Hoel
A1 Per Snorre Lingaas
YR 2020
UL http://openheart.bmj.com/content/7/2/e001278.abstract
AB Aims The aim of this study was the analysis of the risk associated with direct oral anticoagulants (DOACs) in patients undergoing non-elective operations on the proximal aorta due to aortic disease.Methods and results Data from the department’s register of cardiac surgery was analysed retrospectively with emphasis on operative mortality. 135 non-elective operations for proximal aortic disease (October 2016 to 2018) were identified, of which 19 died during the first 90 days. DOAC use was the top-ranked risk factor in the univariate analysis with a HR of 9.6 (3.1 to 29), p=0.00007. Using a Cox proportional hazards model including the most relevant risk factors, the risk associated with DOAC use remained significant with a HR of 6.1 (1.4 to 26.3), p=0.015. We did not find increased risk associated with warfarin use.Conclusion In patients undergoing non-elective operations on the proximal aorta due to aortic disease, the use of DOAC is associated with increased operative mortality.